Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

RANI

Rani Therapeutics Holdings Inc

Dec 13 • 04:00PM ET

1.66

Dollar change -0.08
Percentage change -4.60	%

Healthcare • Biotechnology • USA • NASD

Peers: REGN BMRN SRPT ASND CRSP FATE NTLA EDIT BLUE LBPH

| Held by: VTI VXF HRTS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.06	Insider Own	31.43%	Shs Outstand	29.81M	Perf Week	-13.99%
Market Cap	90.95M	Forward P/E	-	EPS next Y	-1.01	Insider Trans	-18.15%	Shs Float	22.83M	Perf Month	-32.79%
Income	-28.17M	PEG	-	EPS next Q	-0.27	Inst Own	14.32%	Short Float	6.72%	Perf Quarter	-27.19%
Sales	0.00M	P/S	-	EPS this Y	7.89%	Inst Trans	104.94%	Short Ratio	0.86	Perf Half Y	-58.81%
Book/sh	0.10	P/B	15.86	EPS next Y	17.86%	ROA	-49.43%	Short Interest	1.53M	Perf Year	-44.48%
Cash/sh	0.56	P/C	2.94	EPS next 5Y	-9.40%	ROE	-272.52%	52W Range	1.74 - 8.75	Perf YTD	-50.00%
Dividend Est.	-	P/FCF	-	EPS past 5Y	0.28%	ROI	-136.25%	52W High	-81.03%	Beta	0.06
Dividend TTM	-	Quick Ratio	1.60	Sales past 5Y	83.82%	Gross Margin	-	52W Low	-4.60%	ATR (14)	0.14
Dividend Ex-Date	-	Current Ratio	1.60	EPS Y/Y TTM	25.22%	Oper. Margin	-	RSI (14)	28.98	Volatility	6.13% 5.88%
Employees	140	Debt/Eq	10.81	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	11.75
Option/Short	Yes / Yes	LT Debt/Eq	5.62	EPS Q/Q	34.65%	Payout	-	Rel Volume	0.38	Prev Close	1.74
Sales Surprise	-	EPS Surprise	17.24%	Sales Q/Q	-	Earnings	Nov 14 BMO	Avg Volume	1.78M	Price	1.66
SMA20	-15.62%	SMA50	-25.92%	SMA200	-52.38%	Trades		Volume	682,945	Change	-4.60%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-02-24	Initiated	Oppenheimer	Outperform	$17
Jun-14-24	Initiated	Maxim Group	Buy	$15
Jun-13-24	Initiated	Rodman & Renshaw	Buy	$10
Apr-17-23	Resumed	BTIG Research	Buy	$24
Oct-11-22	Initiated	UBS	Buy	$15
Jul-27-22	Initiated	H.C. Wainwright	Buy	$22
Jun-13-22	Initiated	Wedbush	Outperform	$28

Nov-14-24 08:00AM	Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update (GlobeNewswire)
Nov-07-24 04:05PM	Rani Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Oct-17-24 08:00AM	Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist (GlobeNewswire)
Oct-15-24 08:30AM	Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing Warrants (GlobeNewswire) -33.33%
Oct-13-24 06:01AM	Oppenheimer Predicts up to 740% Rally for These 2 Strong Buy Stocks (TipRanks)
04:05PM	Loading…
Oct-08-24 04:05PM	Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit (GlobeNewswire) +7.31%
Sep-03-24 04:05PM	Rani Therapeutics to Participate in September Investor Conferences (GlobeNewswire) -7.50%
Aug-06-24 04:05PM	Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate Update (GlobeNewswire)
Jul-29-24 04:05PM	Rani Therapeutics to Participate in August Investor Conferences (GlobeNewswire)
Jul-22-24 08:30AM	Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering (GlobeNewswire)
Jun-24-24 07:00AM	Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment (GlobeNewswire)
May-16-24 10:15AM	UBS Adjusts Rani Therapeutics Price Target to $8 From $4, Maintains Buy Rating (MT Newswires)
May-14-24 08:00AM	Rani Therapeutics to Participate in May Investor Conferences (GlobeNewswire) -5.40%
May-09-24 08:00AM	Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill Capsule at Digestive Disease Week 2024 (GlobeNewswire) -5.17%
May-07-24 09:06PM	Rani Therapeutics Q1 2024 Earnings: Financial Performance and Strategic Updates (GuruFocus.com)
09:55PM	Loading…
May-06-24 09:55PM	RANI Stock Earnings: Rani Therapeutics Hldgs Beats EPS for Q1 2024 (InvestorPlace) +5.73%
04:05PM	Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update (GlobeNewswire)
Mar-21-24 09:45AM	Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2023 Earnings Call Transcript (Insider Monkey)
06:35AM	Q4 2023 Rani Therapeutics Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-20-24 04:05PM	Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update (GlobeNewswire)
Mar-15-24 04:05PM	Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire) +6.25%
Feb-05-24 08:00AM	Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111) (GlobeNewswire) +5.73%
Dec-14-23 08:00AM	Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist (GlobeNewswire)
Dec-07-23 12:00PM	What Makes Rani Therapeutics Holdings, Inc. (RANI) a New Buy Stock (Zacks)
Nov-08-23 05:53PM	Rani Therapeutics Holdings Inc (RANI) Reports Q3 2023 Financial Results and Corporate Developments (GuruFocus.com)
04:05PM	Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate Update (GlobeNewswire)
Nov-01-23 04:05PM	Rani Therapeutics Announces Strategic Program Prioritization, Expansion of Manufacturing and Plans to Streamline Business Operations to Support Near-Term Value Drivers and Long-Term Growth of the RaniPill Technology Platform; Reports Preliminary Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-25-23 08:00AM	The RaniPill Capsule, Rani Therapeutics' Oral Delivery Platform, was Well-Tolerated in 60-Day, Repeat-Administration, GLP Safety Study (GlobeNewswire)
Oct-19-23 04:05PM	Rani Therapeutics Announces Successful Oral Delivery of Monoclonal Antibody via High-Capacity Pill in Preclinical Study (GlobeNewswire)
Oct-12-23 04:05PM	Rani Therapeutics to Present Abstract on RT-102 at the 2023 Annual Meeting of the American Society for Bone and Mineral Research (GlobeNewswire)
08:00AM	Loading…
Sep-18-23 08:00AM	Rani Therapeutics Initiates Phase 1 Study of RT-111 (RaniPill® Containing Ustekinumab Biosimilar, CT-P43) (GlobeNewswire)
Sep-07-23 04:05PM	Rani Therapeutics Announces Successful Drug Delivery of High-Capacity Pill in Preclinical Studies (GlobeNewswire)
Sep-06-23 08:00AM	Rani Therapeutics to Participate in September Investor Conferences (GlobeNewswire)
Aug-11-23 04:05PM	Rani Therapeutics Reports Second Quarter 2023 Financial Results; Provides Corporate Update (GlobeNewswire)
Aug-04-23 04:05PM	Rani Therapeutics to Participate in August Investor Conferences (GlobeNewswire)
Jun-21-23 08:00AM	Rani Therapeutics Presentation On Oral Delivery of PTH for Osteoporosis Named Presidential Poster Competition Winner at ENDO 2023 Annual Conference (GlobeNewswire)
Jun-08-23 08:00AM	Rani Therapeutics Announces Acceptance of Late-Breaking Abstract of Oral Delivery of GLP-1 Agonist at the American Diabetes Association Annual Conference (GlobeNewswire)
Jun-05-23 08:00AM	Rani Therapeutics and Celltrion Expand Partnership to Include Adalimumab Biosimilar for RT-105 (GlobeNewswire)
Jun-01-23 08:00AM	Rani Therapeutics to Present at the Jefferies Healthcare Conference (GlobeNewswire)
May-31-23 08:00AM	Rani Therapeutics Announces Acceptance of Three Abstracts for Presentation at ENDO 2023 Annual Conference (GlobeNewswire)
May-24-23 08:00AM	Rani Therapeutics Appoints Kate McKinley as Chief Business Officer (GlobeNewswire)
May-17-23 09:50AM	2 Strong Buy Penny Stocks With Over 400% Upside on the Horizon (TipRanks) +12.25%
May-10-23 04:05PM	Rani Therapeutics Reports First Quarter 2023 Financial Results; Provides Corporate Update (GlobeNewswire) -8.84%
Apr-26-23 06:46AM	Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) last week's 14% decline must have disappointed private companies who have a significant stake (Simply Wall St.)
Apr-25-23 08:00AM	Rani Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ (GlobeNewswire)
Apr-11-23 08:00AM	Rani Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-27-23 07:12AM	Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-22-23 04:05PM	Rani Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results; Provides Corporate Update (GlobeNewswire) -6.89%
Mar-16-23 04:05PM	Rani Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Business Updates (GlobeNewswire) +5.71%
Jan-09-23 08:30AM	Celltrion and Rani Therapeutics Partner on Development of Oral Monoclonal Antibody Treatment (GlobeNewswire)
Jan-05-23 04:05PM	Rani Therapeutics Receives Feedback from Pre-IND Meeting with FDA; Provides Pipeline Update (GlobeNewswire) +8.12%
Dec-06-22 04:05PM	Rani Therapeutics Announces Repeat-Dose Topline Results from RT-102 Phase 1 Study (GlobeNewswire) +9.67%
Nov-17-22 05:30AM	Private companies among Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) largest shareholders, saw gain in holdings value after stock jumped 21% last week (Simply Wall St.)
Nov-10-22 05:25PM	Rani Therapeutics Holdings, Inc. (RANI) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Rani Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-09-22 04:05PM	Rani Therapeutics to Present at the Stifel Healthcare Conference (GlobeNewswire)
Oct-28-22 09:55AM	Here's Why Rani Therapeutics Holdings, Inc. (RANI) Is a Great 'Buy the Bottom' Stock Now (Zacks)
Oct-24-22 08:30AM	Rani Therapeutics Announces New RT-111 Development Program and Provides Corporate Update (GlobeNewswire) -10.03%
Sep-27-22 09:06AM	8 Best Stocks to Buy According to Billionaire Marc Lasry (Insider Monkey)
Sep-06-22 04:05PM	Rani Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire)
Aug-11-22 11:47PM	Rani Therapeutics Announces Termination of Public Offering of Class A Common Stock (GlobeNewswire) -25.89% +37.55%
Aug-10-22 05:45PM	Rani Therapeutics Holdings, Inc. (RANI) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
05:28PM	Rani Therapeutics Announces Proposed Public Offering of Class A Common Stock (GlobeNewswire)
04:28PM	Rani Therapeutics Reports Second Quarter 2022 Financial Results; Provides Corporate Update (GlobeNewswire)
04:23PM	Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of RT-102 in Osteoporosis (GlobeNewswire)
Aug-08-22 08:30AM	Rani Therapeutics Enters into $45 Million Loan Agreement to Support Ongoing RaniPill® Platform Advancement and Clinical Pipeline Development (GlobeNewswire)
Aug-03-22 07:48AM	Investors in Rani Therapeutics Holdings (NASDAQ:RANI) have made a return of 16% over the past year (Simply Wall St.)
May-11-22 04:05PM	Rani Therapeutics Reports First Quarter 2022 Financial Results; Provides Corporate Update (GlobeNewswire) -5.75%
May-04-22 03:09PM	Companies Like Rani Therapeutics Holdings (NASDAQ:RANI) Are In A Position To Invest In Growth (Simply Wall St.)
May-03-22 04:05PM	Rani Therapeutics to Present at Upcoming Investor Conferences (GlobeNewswire) -6.19%
07:00AM	Rani Therapeutics RaniPill Capsule Named Winner in the Health Category of Fast Companys 2022 World Changing Ideas Awards (GlobeNewswire)
Apr-07-22 04:05PM	Rani Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-29-22 04:05PM	Rani Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results; Provides Corporate Update (GlobeNewswire)
Mar-23-22 08:38PM	Rani Therapeutics to Release Fourth Quarter and Full Year 2021 Financial Results on Tuesday, March 29, 2022 (GlobeNewswire)
08:00AM	Rani Therapeutics Announces Initiation of Phase 1 Study of RT-102 Oral PTH for Osteoporosis (GlobeNewswire)
Feb-23-22 08:00AM	Rani Therapeutics Unveils High-Capacity RaniPill Device For Oral Delivery of Biologics; Reports Preliminary 2021 Consolidated Financial Results (GlobeNewswire) -8.47%
Jan-19-22 04:30AM	5 Biotech Stocks That Are Bucking the Selloff (Barrons.com) +7.97%
Jan-07-22 08:00AM	Rani Therapeutics Appoints Lisa Rometty to Board of Directors (GlobeNewswire)
Dec-20-21 07:26PM	These are the top 10 best performing newly public Bay Area stocks (American City Business Journals)
Nov-15-21 07:31PM	Rani Therapeutics Reports Third Quarter 2021 Financial Results, Provides Corporate Update (GlobeNewswire)
Nov-12-21 04:05PM	Rani Therapeutics Appoints Lyn Baranowski to Board of Directors (GlobeNewswire)
Nov-10-21 04:05PM	Rani Therapeutics to Participate in a Fireside Chat at the Stifel 2021 Virtual Healthcare Conference (GlobeNewswire) +6.68%
Oct-08-21 12:42PM	Most of this year's flood of new Bay Area public companies are 'under water' (American City Business Journals) +13.29%
Oct-04-21 06:00AM	This Recent Biologics IPO Could Be Heading Toward a Gain of 60% or More (Motley Fool)
Sep-23-21 04:05PM	Rani Therapeutics to Present at Cantor Fitzgerald Virtual Global Healthcare Conference (GlobeNewswire)
Sep-13-21 04:05PM	Rani Therapeutics Reports Second Quarter 2021 Financial Results, Provides Corporate Update (GlobeNewswire) +6.19% -9.15%
Sep-09-21 08:00AM	Rani Therapeutics Announces Appointment of Eric Groen as General Counsel (GlobeNewswire)
Aug-24-21 02:14PM	Rani Therapeutics, RxSight: 2 Bullish Health Care Stock Picks From BofA (Benzinga)
Aug-13-21 04:05PM	Rani Therapeutics Announces Closing of its Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares (GlobeNewswire) +6.77% -16.82%
Jul-30-21 08:56AM	Rani Therapeutics Announces Pricing of Initial Public Offering (GlobeNewswire)

Rani Therapeutics Holdings, Inc. engages in the operation of a clinical stage bio-therapeutics company. The company was founded by Mir Imran on February 21, 2012 and is headquartered in San Jose, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Imran Talat	Chief Executive Officer	Dec 09 '24	Buy	1.94	10,296	19,974	494,751	Dec 10 01:12 PM
South Cone Investments Limited	10% Owner	Oct 15 '24	Sale	2.65	3,829,360	10,141,674	8,302,194	Oct 17 04:30 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RANI

Rani Therapeutics Holdings Inc

Upgrade your FINVIZ experience